JPWO2019191264A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019191264A5 JPWO2019191264A5 JP2020552234A JP2020552234A JPWO2019191264A5 JP WO2019191264 A5 JPWO2019191264 A5 JP WO2019191264A5 JP 2020552234 A JP2020552234 A JP 2020552234A JP 2020552234 A JP2020552234 A JP 2020552234A JP WO2019191264 A5 JPWO2019191264 A5 JP WO2019191264A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- pharmaceutical composition
- aqueous pharmaceutical
- concentration
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862648746P | 2018-03-27 | 2018-03-27 | |
| US62/648,746 | 2018-03-27 | ||
| PCT/US2019/024331 WO2019191264A1 (en) | 2018-03-27 | 2019-03-27 | Peptide-containing formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519321A JP2021519321A (ja) | 2021-08-10 |
| JP2021519321A5 JP2021519321A5 (https=) | 2022-03-31 |
| JPWO2019191264A5 true JPWO2019191264A5 (https=) | 2022-03-31 |
Family
ID=66103053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020552234A Abandoned JP2021519321A (ja) | 2018-03-27 | 2019-03-27 | ペプチド含有製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11517608B2 (https=) |
| EP (1) | EP3773627A1 (https=) |
| JP (1) | JP2021519321A (https=) |
| KR (1) | KR20200139723A (https=) |
| CN (1) | CN112040958A (https=) |
| AU (1) | AU2019243724A1 (https=) |
| CA (1) | CA3097341A1 (https=) |
| IL (1) | IL277466A (https=) |
| MX (1) | MX2020010085A (https=) |
| TW (1) | TW202002996A (https=) |
| WO (1) | WO2019191264A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113876929B (zh) * | 2021-11-22 | 2024-02-23 | 中国人民解放军陆军军医大学 | 肽MOTS-c在制备治疗帕金森药物中的应用 |
| CN115444926A (zh) * | 2022-05-10 | 2022-12-09 | 江南大学 | MOTS-c肽及其衍生物在制备放射性肺损伤治疗药物中的应用 |
| CN118236470A (zh) * | 2024-03-29 | 2024-06-25 | 无锡市第二人民医院 | MOTS-c肽及其衍生物在制备支气管哮喘治疗药物中的应用 |
| CN119241659B (zh) * | 2024-10-08 | 2025-09-19 | 西北大学 | MOTS-c及其氨基酸突变多肽在伤口愈合方面的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001076532A2 (en) | 2000-04-11 | 2001-10-18 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| US8309525B2 (en) | 2007-05-30 | 2012-11-13 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof |
| AU2008269954A1 (en) | 2007-06-29 | 2009-01-08 | Centocor Ortho Biotech Inc. | Anti- MCP-1 antibodies, compositions, methods and uses |
| US7998928B2 (en) | 2007-09-14 | 2011-08-16 | The Regents Of The University Of California | Method of treatment of type-1 diabetes with a humanin analogue |
| WO2009135165A2 (en) | 2008-05-01 | 2009-11-05 | The Regents Of The University Of California | Small humanin-like peptides |
| WO2012009709A1 (en) | 2010-07-16 | 2012-01-19 | Sudhir Paul | Hiv cd4 binding site based covalent immunogen compositions |
| US20130123168A1 (en) | 2011-06-17 | 2013-05-16 | The Regents Of The University Of California | Humanin and humanin-analogues for the management of atherosclerosis |
| BR112015023500B1 (pt) * | 2013-03-15 | 2021-01-12 | The Regents Of The University Of California | composição farmacêutica |
| TW201819398A (zh) * | 2016-09-28 | 2018-06-01 | 美商寇峇有限公司 | 治療性肽 |
-
2019
- 2019-03-27 US US16/981,870 patent/US11517608B2/en active Active
- 2019-03-27 KR KR1020207030897A patent/KR20200139723A/ko not_active Withdrawn
- 2019-03-27 CN CN201980026908.0A patent/CN112040958A/zh active Pending
- 2019-03-27 AU AU2019243724A patent/AU2019243724A1/en not_active Abandoned
- 2019-03-27 JP JP2020552234A patent/JP2021519321A/ja not_active Abandoned
- 2019-03-27 WO PCT/US2019/024331 patent/WO2019191264A1/en not_active Ceased
- 2019-03-27 EP EP19717170.5A patent/EP3773627A1/en not_active Withdrawn
- 2019-03-27 TW TW108110719A patent/TW202002996A/zh unknown
- 2019-03-27 CA CA3097341A patent/CA3097341A1/en active Pending
- 2019-03-27 MX MX2020010085A patent/MX2020010085A/es unknown
-
2020
- 2020-09-21 IL IL277466A patent/IL277466A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2405994T3 (es) | Soluciones estabilizadas de teriparatide | |
| TW434259B (en) | Acylated insulin analogs | |
| US20250064898A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
| JP3295430B2 (ja) | グルカゴンを含んでなる医薬製剤 | |
| JP2021519321A5 (https=) | ||
| JP5015411B2 (ja) | 生体活性剤の改良された細胞取り込み | |
| CN100475267C (zh) | 含甘氨酸的高浓度人生长激素液体制剂 | |
| TW201127395A (en) | Pharmaceutical composition comprising a GLP-1 agonist and methionine | |
| TW201105346A (en) | Heat-stable and vibration-stable insulin preparations | |
| JPH02101022A (ja) | 糖尿病治療用医薬組成物 | |
| JPH0925238A (ja) | 経鼻投与用製剤 | |
| CN103338790A (zh) | 用聚乙二醇或其衍生物聚乙二醇化的唾液素-4类似物、其制备方法以及含有其作为活性成分的用于预防或治疗糖尿病的药物组合物 | |
| CN114796462A (zh) | 一种长效glp-1衍生物的药物制剂 | |
| TW201100093A (en) | Preparation comprising insulin, nicotinamide and an amino acid | |
| JP7060589B2 (ja) | ポリエチレングリコールロキセナチドを含有する薬物製剤及びその製造方法 | |
| TWI247608B (en) | Growth hormone formulations | |
| US20190060410A1 (en) | Pharmaceutical Formulation Comprising GLP-1 Analogue and Preparation Method Thereof | |
| JP2014515747A (ja) | 医薬組成物 | |
| ES3019509T3 (en) | Pharmaceutical composition of glp-1/glp-2 dual agonists | |
| JPWO2019191264A5 (https=) | ||
| JPWO2020065064A5 (https=) | ||
| CN102133200B (zh) | 一种人类松弛素-2 Relaxin的注射用冻干粉制剂 | |
| CN102342931A (zh) | 替莫唑胺的可注射的胃肠外用药物制剂及其制备方法 | |
| AU2009218060B2 (en) | Pharmaceutical composition for transnasal administration | |
| CN102283818A (zh) | 多肽和蛋白质类药物口服肠溶胶囊及其制备方法 |